Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users

References

• Aitken, C., Delalande, C., & Stanton, K. (2002). Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic–androgenic steroid injectors in Victoria, Australia. Drug and Alcohol Dependence, 65, 303–308. doi:10.1016/S0376-8716(01)00174-0
   PubMed Web of Science ®Google Scholar
• Bagatell, C. J., & Bremmer, W. J. (1996). Androgens in men − uses and abuses. The New England Journal of Medicine, 334, 707–715. doi:10.1056/NEJM199603143341107
   PubMed Web of Science ®Google Scholar
• Barnard, M. A. (1993). Needle sharing in context: Patterns of sharing among men and women injectors and HIV risks. Addiction, 88, 805–812. doi: 10.1111/j.1360-0443.1993.tb02094.x
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006). Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 91, 1995–2010. doi:10.1210/jc.2005-2847
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Storer, T. W., Javanbakht, M., Berman, N., Yarasheski, K. E., Phillips, J., … Beall, G. (2000). Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. The Journal of the American Medical Association, 283, 763–770. doi:10.1001/jama.283.6.763
   PubMed Web of Science ®Google Scholar
• Bolding, G., Sherr, L., & Elford, J. (2002). Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction, 97, 195–203. doi:10.1046/j.1360-0443.2002.00031.x
   PubMed Web of Science ®Google Scholar
• Bolding, G., Sherr, L., Maguire, M., & Elford, J. (1999). HIV risk behaviours among gay men who use anabolic steroids. Addiction, 94, 1829–1835. doi:10.1046/j.1360-0443.1999.941218298.x
   PubMed Web of Science ®Google Scholar
• Broz, D., Wejnert, C., Pham, H. T., DiNenno, E., Heffelfinger, J. D., Cribbin, M., … Paz-Bailey, G. (2014). HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. Morbidity and Mortality Weekly Report. Surveillance Summaries, 63(6), 1–51. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6306a1.htm
   Google Scholar
• Burton, C. (1996). Anabolic steroid use among the gym population in Clwyd. Pharmaceutical Journal, 256, 557–559.
   Google Scholar
• Centers for Disease Control and Prevention. (2002). Drug-associated HIV transmission continues in the United States [PDF document]. Retrieved from http://www.cdc.gov/hiv/resources/factsheets/PDF/idu.pdf.
   Google Scholar
• Centers for Disease Control and Prevention. (2010a). Hepatitis B – general information [PDF document]. Retrieved from http://www.cdc.gov/hepatitis/HBV/PDFs/HepBGeneralFactSheet.pdf.
   Google Scholar
• Centers for Disease Control and Prevention. (2010b). Hepatitis C – general information [PDF document]. Retreived from http://www.cdc.gov/hepatitis/HCV/PDFs/HepCGeneralFactSheet.pdf
   Google Scholar
• Centers for Disease Control and Prevention. (2013). HIV among gay and bisexual Men [PDF document]. Retrieved from http://www.cdc.gov/hiv/pdf/risk_gender_238900B_HIV_Gay_Bisexual_MSM_FS_final.pdf
   Google Scholar
• Centers for Disease Control and Prevention. (2014). STDs and HIV – CDC fact sheet [PDF document]. Retrieved from http://www.cdc.gov/std/hiv/hiv-std-factsheet-dec-2014.pdf
   Google Scholar
• Chandra, A., Billioux, V. G., Copen, C. E., & Sionean, C. (2012). HIV risk-related behaviors in the United States household population aged 15–44: Data from the National Survey of Family Growth, 2002 and 2006–2010. National Health Statistics Reports; Number 46 [PDF document]. Hyattsville, MD: National Center for Health Statistics; 2012. Retrieved January 21, 2015, from http://www.cdc.gov/nchs/data/nhsr/nhsr046.pdf
   Google Scholar
• Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. Journal of the International Society of Sports Nutrition, 4, 12. doi:10.1186/1550-2783-4-12
   PubMed Web of Science ®Google Scholar
• Crampin, C. A., Lamagni, T. L., Hope, V. D., Newham, J. A., Lewis, K. M., Parry, J. V., & Gill, O. N. (1998). The risk of infection with HIV and Hepatitis B in individuals who inject steroids in England and Wales. Epidemiology and Infection, 121, 381–386. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809535/pdf/9825789.pdf doi: 10.1017/S0950268898001265
   PubMed Web of Science ®Google Scholar
• Day, C. A., Topp, L., Iversen, J., & Maher, L. (2008). Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey. Drug and Alcohol Review, 27(5), 559–561. doi: 10.1080/09595230801956132
   PubMed Web of Science ®Google Scholar
• Delalande, C. L., Aitken, C. K., Mercuri, P., & Stanton, K. A. (1998). Risky practices among people who inject steroids. The Medical Journal of Australia, 169(1), 62.
   PubMed Web of Science ®Google Scholar
• DuRant, R. H., Rickert, V. I., Ashworth, C. S., Newman, C., & Slavens, G. (1993). Use of multiple drugs among adolescents who use anabolic steroids. The New England Journal of Medicine, 328(13), 922–926. doi: 10.1056/NEJM199304013281304
   PubMed Web of Science ®Google Scholar
• Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014). Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology, 61(Suppl. 1), S45–S57. doi:10.1016/j.jhep.2014.07.027
   PubMed Web of Science ®Google Scholar
• Grace, F. M., Baker, J., & Davies, B. (2001). Anabolic androgenic steroid use in recreational gym users: A regional sample of the Mid-Glamorgan area. Journal of Substance Use, 6(3), 189–195. doi: 10.1080/14659890152558804
   Google Scholar
• Hoffman, J. R., Kraemer, W. J., Bhasin, S., Storer, T., Ratamess, N. A., Haff, G. G., … Rogol, A. D. (2009). Position stand on androgen and human growth hormone use. Journal of Strength and Conditioning Research, 23(Suppl. 5), S1–S59. doi:10.1519/JSC.0b013e31819df2e6
   Google Scholar
• Hope, V. D., McVeigh, J., Marongiu, A., Evans-Brown, M., Smith, J., Kimergård, A., … Ncube, F. (2013). Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study. BMJ Open, 3(9), e003207. doi:10.1136/bmjopen-2013-003207
   PubMed Web of Science ®Google Scholar
• Hope, V., Parry, J. V., Marongui, A., & Ncube, F. (2012). Hepatitis C infection among recent initiates to injecting in England 2000–2008: Is a national hepatitis C action plan making a difference? Journal of Viral Hepatitis, 19(1), 55–64. doi:10.1111/j.1365-2893.2010.01415.x
   PubMed Web of Science ®Google Scholar
• Ip, E. J., Barnett, M. J., Tenerowicz, M. J., & Perry, P. J. (2011). The anabolic 500 survey: Characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy, 31(8), 757–766. doi:10.1592/phco.31.8.757
   PubMed Web of Science ®Google Scholar
• Ip, E. J., Lu, D. H., Barnett, M. J., Tenerowicz, M. J., Vo, J. C., & Perry, P. J. (2012). Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy, 32(10), 910–919. doi:10.1002/j.1875-9114.2012.01123
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. (2012). 2012 Report on the global AIDS epidemic [PDF document]. Retrieved from http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf
   Google Scholar
• Kanayama, G., Hudson, J. I., & Pope, H. G. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1–2), 1–12. doi:10.1016/j.drugalcdep.2008.05.004
   PubMed Web of Science ®Google Scholar
• Kimergård, A., & McVeigh, J. (2014). Variability and dilemmas in harm reduction for anabolic steroid users in the UK: A multi-area interview study. Harm Reduction Journal, 11(19), 1–13.
   PubMed Web of Science ®Google Scholar
• Korkia, P., & Stimson, G. (1993). Anabolic steroid use in Great Britain: An exploratory investigation. Final report to the Department of Health for England, Scotland and Wales. London: The Centre for Research on Drugs and Health Behaviour.
   Google Scholar
• Kuhn, C. M. (2002). Anabolic steroids. Recent Progress in Hormone Research, 57, 411–434. Retrieved from http://press.endocrine.org/page/rphr
   Google Scholar
• Larance, B., Degenhardt, L., Copeland, J., & Dillon, P. (2008). Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug and Alcohol Review, 27(6), 679–686. doi:10.1080/09595230802392568
   PubMed Web of Science ®Google Scholar
• Lenaway, D. D., Guilfoile, A., & Rebchook, G. (1992). Multiple HIV risk behaviours among injecting steroid users. AIDS & Public Policy Journal, 7, 184–186.
   Google Scholar
• Lenehan, P., Bellis, M., & McVeigh, J. (1996). A study of anabolic steroid use in the North West of England. The Journal of Performance Enhancing Drugs, 1(2), 57–70.
   Google Scholar
• Midgley, S. J., Heather, N., Best, D., Henderson, D., McCarthy, S., & Davies, J. B. (2000). Risk behaviors for HIV and hepatitis infection among anabolic-androgenic steroid users. AIDS Care, 12(2), 163–170. doi:10.1080/09540120050001832
   PubMed Web of Science ®Google Scholar
• Morrison, C. L. (1994). Anabolic steroid users identified by needle and syringe exchange contact. Drug and Alcohol Dependence, 36(2), 153–155. doi:10.1016/0376-8716(94)90098-1
   PubMed Web of Science ®Google Scholar
• Nemechek, P. M. (1991). Anabolic steroid users – another potential risk group for HIV infection. The New England Journal of Medicine, 325(5), 357–357.
   PubMed Web of Science ®Google Scholar
• O'Sullivan, A. J., Kennedy, M. C., Casey, J. H., Day, R. O., Corrigan, B., & Wodak, A. D. (2000). Anabolic-androgenic steroids: Medical assessment of present, past and potential users. The Medical Journal of Australia, 173, 323–327. Retrieved from https://www.mja.com.au/
   PubMed Web of Science ®Google Scholar
• Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012). Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine, 30(12), 2212–2219. doi:10.1016/j.vaccine.2011.12.116
   PubMed Web of Science ®Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: A survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651. doi:10.1249/01.mss.0000210194.56834.5d
   PubMed Web of Science ®Google Scholar
• Pates, R., & Barry, C. (1996). Steroid use in Cardiff: A problem for whom? The Journal of Performance Enhancing Drugs, 1(3), 92–97.
   Google Scholar
• Perry, H. M., Wright, D., & Littlepage, B. N. (1992). Dying to be big: A review of anabolic steroid use. British Journal of Sports Medicine, 26, 259–261. doi:10.1136/bjsm.26.4.259
   PubMedGoogle Scholar
• Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocrine Reviews, 35(3), 341–375. doi:10.1210/er.2013-1058
   PubMed Web of Science ®Google Scholar
• Rich, J. D., Dickinson, B. P., Feller, A., Pugatch, D., & Mylonakis, E. (1999). The infectious complications of anabolic-androgenic steroid injection. International Journal of Sports Medicine, 20, 563–566. doi:10.1055/s-1999-8841
   PubMed Web of Science ®Google Scholar
• Scott, M. J., & Scott Jr., M. J. (1989). HIV infection associated with injections of anabolic steroids. JAMA: the Journal of the American Medical Association, 262(2), 207–208. doi: 10.1001/jama.1989.03430020049017
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., & Kean, J. (2015). An exploratory study of image and performance enhancement drug use in a male British South Asian community. International Journal on Drug Policy. Advance. doi:10.1016/j.drugpo.2015.03.002
   Web of Science ®Google Scholar
• Winter, R. J., Dietze, P. M., Gouillou, M., Hellard, M. E., Robinson, P., & Aitken, C. K. (2013). Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: What has been the impact of targeted free vaccination? Journal of Gastroenterology and Hepatology, 28(2), 314–322. doi:10.1111/jgh.12063
   PubMed Web of Science ®Google Scholar